Nytol Original è un rimedio clinicamente provato per l'insonnia. È stato dimostrato di aiutare gli insonni ad addormentarsi più velocemente, a dormire più a lungo e più profondi e svegliarsi sentendosi rinfrescato al mattino.

Nytol Original e Nytol One-a Night Products non differiscono per il dosaggio, solo il numero di tablet che prendi. Due tavolette per Nytol Original e solo una per Nytol One-a Night.

Come prendere i tablet originali di Nytol:

• Prendi due tavolette originali NYTOL con acqua 20 minuti prima di andare a letto.
• Poiché questo prodotto ha lo scopo di aiutarti a dormire bene la notte, è meglio prenderlo almeno 7 o 8 ore prima che tu debba svegliarti.
• Se usi questo prodotto su base regolare, potrebbe diventare meno efficace.
• Consultare il medico o un farmacista se i sintomi non migliorano e non prendono queste compresse per più di due settimane.

Le compresse originali di nytol contengono difenidramina 25mg per compressa. 

Le immagini mostrate sono solo a scopo di illustrazione e potrebbero non rappresentare accuratamente il prodotto specifico.

The active substance: Each tablet contains Diphenhydramine Hydrochloride 25mg.The other ingredients are: Anhydrous Lactose, Microcrystalline Cellulose, Maize Starch, Stearic Acid and Silicon Dioxide.

Welzo non è responsabile per le discrepanze sul sito Web. Controllare l'imballaggio del prodotto per informazioni esatte.

Regno Unito e Resto del mondo Dettagli di spedizione:
Lo stesso giorno invio per gli ordini effettuati entro le 14:00 (ordini dopo le 14:00 ha inviato il giorno di lavoro successivo).

Spedizione gratuita per ordini £50 nel Regno Unito.

Ritorni: I nostri prodotti hanno lo scopo di farti sentire sano e al meglio. Se è necessario restituire il tuo articolo, puoi farlo gratuitamente entro 30 giorni nello stesso imballaggio originale e non aperto. Soggetto a T&C.

1-2 tablets 30-60 minutes before bedtime.

Welzo non è responsabile per le informazioni sugli allergeni. Seguire sempre le indicazioni/gli ingredienti sulla confezione del prodotto per garantire un uso corretto.

Nytol is contraindicated in patients who are hypersensitive to diphenhydramine or any of the excipients and in those with the following conditions: stenosing peptic ulcer, pyloroduodenal obstruction.

Nytol should be used with caution in patients with myasthenia gravis, epilepsy or seizure disorders, narrow-angle glaucoma, prostatic hypertrophy, urinary retention, asthma, bronchitis and chronic obstructive pulmonary disease (COPD), moderate to severe hepatic impairment and moderate to severe renal impairment.

Tolerance may develop with continuous use. Seek medical advice if sleeplessness persists, as insomnia may be a symptom of serious underlying medical illness.

May increase the effects of alcohol, therefore alcohol should be avoided.

Avoid use of other antihistamine-containing preparations, including topical antihistamines and cough and cold medicines.

Use with caution in the elderly, who are more likely to experience adverse effects. Avoid use in elderly patients with confusion.

Patients with rare hereditary problems of galactose intolerance, the Lapp lactase deficiency or glucose-galactose malabsorption should not take this medicine.

Keep out of the reach and sight of children.

Diphenhydramine may potentiate the sedative effects of alcohol and other CNS depressants (e.g. tranquillizers, hypnotics and anxiolytics).

Monoamine oxidase inhibitors(MAOI) prolong and intensify the anticholinergic effects of diphenhydramine. The product should be used with caution with MAOIs or within 2 weeks of stopping an MAOI.

As diphenhydramine has some antimuscarinic activity, the effects of some anticholinergic drugs (e.g. atropine, tricyclic antidepressants) may be potentiated therefore medical advice should be sought before taking diphenhydramine with such medicines.

Diphenhydramine is an inhibitor of the cytochrome p450 isoenzyme CYP2D6. Therefore, there may be a potential for interaction with drugs which are primarily metabolised by CYP2D6, such as metoprolol and venlafaxine.

Diphenhydramine should not be used in patients receiving any of the above drugs unless directed by a doctor.

Pregnancy
Diphenhydramine crosses the placenta. Because animal reproduction studies are not always predictive of human response and since there is inadequate experience with use of diphenhydramine in pregnant women, the potential risk for humans is unknown. Use of sedating antihistamines during the third trimester may result in reactions in the newborn or premature neonates. This drug is not recommended during pregnancy. Consult a doctor before use.

Lactation
Diphenhydramine has been detected in breast milk, but the effect of this on breastfed infants is unknown. Nytol is not recommended for use during lactation. Consult a doctor before use.

Nytol is a hypnotic and will produce drowsiness or sedation soon after the dose has been taken. It may also cause dizziness, blurred vision, cognitive and psychomotor impairment. These can seriously affect the patient's ability to drive and use machines. If affected, do not drive or operate machinery.

Overdose is likely to result in effects similar to those listed under adverse reactions. Additional symptoms may include mydriasis, fever, flushing, agitation, tremor, dystonic reactions, hallucinations and ECG changes. Large overdose may cause rhabdomyolysis, convulsions, delirium, toxic psychosis, arrhythmias, coma and cardiovascular collapse.

Treatment should be supportive and directed towards specific symptoms. Convulsions and marked CNS stimulation should be treated with parenteral diazepam.

Nytol Original Tablets PIL